MAZE
Maze Therapeutics, Inc. · Healthcare
Chief Executive Officer Jason Coloma V sold $907K of Maze Therapeutics, Inc.
Sold$906,999
$26.29Price
34,501Shares
−13%Stake
What MAZE did after the filing
- The stock from Fri, Sep 4 open, $25.77
- +1.1%
- S&P 500, same days
- −0.1%
14 of 30 trading days so far, to the Sep 25 close.
Traded Tue, Sep 1. Filed Thu, Sep 3, 4:27 PM ET, after the close. Returns use the Sep 4 open and the Sep 25 close. Not investment advice.